Prevalence of genetic mutations that predispose to thrombophilia in a Greek Cypriot population

被引:38
作者
Angelopoulou, K [1 ]
Nicolaides, A [1 ]
Deltas, CC [1 ]
机构
[1] Cyprus Inst Neurol & Genet, Dept Mol Genet, CY-1683 Nicosia, Cyprus
关键词
factor V; prothrombin; methylene-tetrahydrofolate reductase (MTHFR); thrombophilia; molecular epidemiology;
D O I
10.1177/107602960000600211
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several hereditary disorders, particularly those affecting the physiological anticoagulation systems, have been well established as risk factors for venous thromboembolism. In the present study, we investigated the prevalence of the following thrombogenic mutations in a Greek-Cypriot population: the G1691 factor V Leiden mutation, the G20210A mutation in the prothrombin gene, and the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR). All three variants have been documented to be significant risk factors for various cardiovascular conditions. Ninety unrelated subjects were screened. For the Leiden mutation, 11 subjects (12.2%) were heterozygous and one (1.1%) was homozygous. Seven subjects (7.8%) were heterozygous for the G20210A variant in prothrombin; no homozygotes were identified. The C677T mutation in MTHFR was found in 40 individuals in the heterozygous state (44.4%), and in 16 individuals in the homozygous state (17.8%). These data demonstrate that Greek-Cypriots have an increased Frequency of thrombogenic mutations, and suggest that screening for these mutations should be seriously considered, especially when surgery or pregnancy is planned. This is the first study for the frequency of mutations in risk factors that predispose to thrombophilia on the island of Cyprus.
引用
收藏
页码:104 / 107
页数:4
相关论文
共 17 条
[1]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[2]  
Bloom A. L., 1994, HAEMOSTASIS THROMBOS, V1, P397
[3]  
Cattaneo M., 1996, Blood, V88, p285A
[4]   The prothrombin gene G20210A variant: Prevalence in a UK anticoagulant clinic population [J].
Cumming, AM ;
Keeney, S ;
Salden, A ;
Bhavnani, M ;
Shwe, KH ;
Hay, CRM .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (02) :353-355
[5]  
DAHLBACK B, 1994, MOL BASIS BLOOD DISE, P599
[6]   Hyperhomocysteinemia as a risk factor for deep-vein thrombosis [J].
denHeijer, M ;
Koster, T ;
Blom, HJ ;
Bos, GMJ ;
Briet, E ;
Reitsma, PH ;
Vandenbroucke, JP ;
Rosendaal, FR .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (12) :759-762
[7]   A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE [J].
FROSST, P ;
BLOM, HJ ;
MILOS, R ;
GOYETTE, P ;
SHEPPARD, CA ;
MATTHEWS, RG ;
BOERS, GJH ;
DENHEIJER, M ;
KLUIJTMANS, LAJ ;
VANDENHEUVEL, LP ;
ROZEN, R .
NATURE GENETICS, 1995, 10 (01) :111-113
[8]  
Kluijtmans LAJ, 1996, AM J HUM GENET, V58, P35
[9]   VENOUS THROMBOSIS DUE TO POOR ANTICOAGULANT RESPONSE TO ACTIVATED PROTEIN-C - LEIDEN THROMBOPHILIA STUDY [J].
KOSTER, T ;
ROSENDAAL, FR ;
DERONDE, H ;
BRIET, E ;
VANDENBROUCKE, JP ;
BERTINA, RM .
LANCET, 1993, 342 (8886-7) :1503-1506
[10]   Increased frequency of genetic thrombophilia in women with complications of pregnancy [J].
Kupferminc, MJ ;
Eldor, A ;
Steinman, N ;
Many, A ;
Bar-Am, A ;
Jaffa, A ;
Fait, G ;
Lessing, JB .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (01) :9-13